Welcome to

He Ako Hiringa

We provide education and resources for primary care health professionals, based on guidelines and clinical evidence. Patients, please contact your usual health provider for medical advice.

Supply issues may sometimes affect the information given – please check the Pharmac medicine notices page for current supply issues

Our latest content

2 minutes to Read

Morphine oral liquid RA-Morph 1mg/ml and 10mg/ml are now out of stock, and the remaining strengths expire at the end of March. Wockhardt brand 10mg/5ml (2mg/ml) is available instead, and Oramorph 2mg/ml will be available soon - both are Section 29 medicines.

Read this article for important points to note. 

Contributor
He Ako Hiringa
21 November 2023

To date, two oral antiviral agents have been approved in Aotearoa New Zealand for treating COVID-19 in adults who are at increased risk of progressing to severe disease, hospitalisation or death. This article reports on the uptake of these medicines between April 2022 and December 2023, based on dispensing data provided by Te Whatu Ora.

Contributor
He Ako Hiringa
26 February 2024

Chronic hepatitis C can cause cirrhosis, liver failure, cancer and early death. Raising awareness that hep C can be cured with a short course of oral antivirals is vital. Read this microlearning to find out more.

Contributor
He Ako Hiringa
1 February 2024
60 minutes to Watch

This video is a recording of the live webinar hosted by Mobile Health on 30 November 2023. Dr David McNamara explores the importance of childhood asthma diagnosis, management, disparities and inhaler technique. Dr Burrell then discusses the impact of inhaler propellants on the environment, and how we can minimise harm.

14 December 2023
1 minute to Read + 30 minutes to Listen

Episode seven of our Legendary Conversations podcast explores hepatitis C. Dr Sarah Hartnall, and nurses Nancy Carey and Bridget Faire discuss hepatitis C testing, treatment, and support networks in Aotearoa. 

Contributor
He Ako Hiringa
5 December 2023

Thirsty for knowledge?

Subscribe to our newsletter to remain up to date with all our content and new features.